-
1
-
-
1442359548
-
Topiramate for migraine prevention a randomized controlled trial
-
Brandes J, Saper J, Diamond M et al. (2004) Topiramate for migraine prevention a randomized controlled trial. JAMA 291:965-973
-
(2004)
JAMA
, vol.291
, pp. 965-973
-
-
Brandes, J.1
Saper, J.2
Diamond, M.3
-
2
-
-
0041592746
-
Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: A randomized, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet
-
Charlesworth B, Dowson A, Purdy A et al. (2003) Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomized, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. CNS Drugs 17:653-667
-
(2003)
CNS Drugs
, vol.17
, pp. 653-667
-
-
Charlesworth, B.1
Dowson, A.2
Purdy, A.3
-
3
-
-
0037214004
-
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine
-
Christie S, Gobel H, Mateos V et al. (2002) Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol 49:20-29
-
(2002)
Eur Neurol
, vol.49
, pp. 20-29
-
-
Christie, S.1
Gobel, H.2
Mateos, V.3
-
4
-
-
0036179286
-
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (cafergot) in the acute treatment of migraine a multicentre, randomized, double-blind, placebo-controlled comparison
-
Diener HC, Reches A, Pascual J et al. (2002) Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (cafergot) in the acute treatment of migraine a multicentre, randomized, double-blind, placebo-controlled comparison. Eur Neurol 47:99-107
-
(2002)
Eur Neurol
, vol.47
, pp. 99-107
-
-
Diener, H.C.1
Reches, A.2
Pascual, J.3
-
6
-
-
1242337418
-
The 40-mg dose of eletriptan: Comparative efficacy and tolerability versus sumatriptan 100 mg
-
Diener H, Ryan R, Sun W et al. (2004) The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg. Eur J Neurol 11:125-134
-
(2004)
Eur J Neurol
, vol.11
, pp. 125-134
-
-
Diener, H.1
Ryan, R.2
Sun, W.3
-
7
-
-
0036632560
-
Almotriptan is an effective and well-tolerated treatment for migraine pain: Results of a randomized, double-blind, placebo-controlled clinical trial
-
Dowson AJ, Massiou H, Lainez JM et al. (2002) Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia 22:453-461
-
(2002)
Cephalalgia
, vol.22
, pp. 453-461
-
-
Dowson, A.J.1
Massiou, H.2
Lainez, J.M.3
-
8
-
-
0038798478
-
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan
-
Farkkila M, Olesen J, Dahlof C et al. (2003) Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 23:463-471
-
(2003)
Cephalalgia
, vol.23
, pp. 463-471
-
-
Farkkila, M.1
Olesen, J.2
Dahlof, C.3
-
9
-
-
0035904760
-
Oral triptans (serotonin S-HT(1B/1D) agonists) in acute migraine treatment a meta-analysis of 53 trials
-
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin S-HT(1B/1D) agonists) in acute migraine treatment a meta-analysis of 53 trials. Lancet 358:1668-1675
-
(2001)
Lancet
, vol.358
, pp. 1668-1675
-
-
Ferrari, M.D.1
Roon, K.I.2
Lipton, R.B.3
Goadsby, P.J.4
-
10
-
-
0042856459
-
An open-label pilot study on the efficacy and tolerability of levetiracetarn in the prophylaxis of migraine
-
Gallai V, Alberti A, Rossi C et al. (2003) An open-label pilot study on the efficacy and tolerability of levetiracetarn in the prophylaxis of migraine. J Headache Pain 4:92-96
-
(2003)
J Headache Pain
, vol.4
, pp. 92-96
-
-
Gallai, V.1
Alberti, A.2
Rossi, C.3
-
11
-
-
0242267005
-
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine
-
Garcia-Ramos G, MacGregor E, Milliard B et al. (2003) Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia 23:869-876
-
(2003)
Cephalalgia
, vol.23
, pp. 869-876
-
-
Garcia-Ramos, G.1
MacGregor, E.2
Milliard, B.3
-
12
-
-
0033982573
-
Eletriptan in acute migraine a double-blind, placebo-controlled comparison to sumatriptan
-
Goadsby PJ, Ferrari MD, Olesen J et al. (2000) Eletriptan in acute migraine a double-blind, placebo-controlled comparison to sumatriptan. Neurology 54:156-163
-
(2000)
Neurology
, vol.54
, pp. 156-163
-
-
Goadsby, P.J.1
Ferrari, M.D.2
Olesen, J.3
-
13
-
-
0010531282
-
A comparison of the efficacy and tolerability of naratriptan and sumatriptan among migraineurs with a history of frequent (50% of attacks) headache recurrence
-
Poster, Amsterdam
-
Göbel H, Boswell D, Winter PDO et al. (1997) A comparison of the efficacy and tolerability of naratriptan and sumatriptan among migraineurs with a history of frequent (50% of attacks) headache recurrence. Poster, VIIIth IHS Congress, Amsterdam, pp 163-165
-
(1997)
VIIIth IHS Congress
, pp. 163-165
-
-
Göbel, H.1
Boswell, D.2
Winter, P.D.O.3
-
14
-
-
0032423808
-
Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 and 50 mg in migraine
-
Goldstein J, Ryan R, Jiang K et al. (1998) Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 and 50 mg in migraine. Headache 38:737-747
-
(1998)
Headache
, vol.38
, pp. 737-747
-
-
Goldstein, J.1
Ryan, R.2
Jiang, K.3
-
15
-
-
0346031709
-
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
-
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain Cephalalgia 8 [suppl 7]:1-93
-
(1988)
Cephalalgia
, vol.8
, Issue.SUPPL. 7
, pp. 1-93
-
-
-
16
-
-
5644252500
-
Intravenous valproic acid in the treatment of acute migrain attacks. A comparison with intravenous acetylsalicylic acid
-
in press
-
Leniger T, Pageler L, Diener HC, Limmroth V (2004) Intravenous valproic acid in the treatment of acute migrain attacks. A comparison with intravenous acetylsalicylic acid. Headache, in press
-
(2004)
Headache
-
-
Leniger, T.1
Pageler, L.2
Diener, H.C.3
Limmroth, V.4
-
17
-
-
0037345717
-
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg
-
Mathew N, Schoenen J, Winner P et al. (2003) Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. Headache 43:214-222
-
(2003)
Headache
, vol.43
, pp. 214-222
-
-
Mathew, N.1
Schoenen, J.2
Winner, P.3
-
18
-
-
0141923810
-
Tolerability and safety of eletriptan in the treatment of migraine: A comprehensive review
-
Mathew N, Hettiarachchi J, Alderman J (2003)Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review. Headache 41:962-974
-
(2003)
Headache
, vol.41
, pp. 962-974
-
-
Mathew, N.1
Hettiarachchi, J.2
Alderman, J.3
-
19
-
-
1442265540
-
The international classification of headache disorders
-
2nd edn.
-
Olesen J, Bousser M-G, Diener H et al. (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24 [suppl 1]:1-160
-
(2004)
Cephalalgia
, vol.24
, Issue.SUPPL. 1
, pp. 1-160
-
-
Olesen, J.1
Bousser, M.-G.2
Diener, H.3
-
20
-
-
1542346238
-
Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks
-
Olesen J, Diener H, Husstedt IW et al. (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS is effective in the treatment of migraine attacks. N Engl J Med 350:1104-1110
-
(2004)
N Engl J Med
, vol.350
, pp. 1104-1110
-
-
Olesen, J.1
Diener, H.2
Husstedt, I.W.3
-
21
-
-
0034995238
-
Tolerability and efficacy of almotriptan in the long-term treatment of migraine
-
Pascual J, Falk R, Docekal R et al. (2001) Tolerability and efficacy of almotriptan in the long-term treatment of migraine. Eur Neurol 45:206-213
-
(2001)
Eur Neurol
, vol.45
, pp. 206-213
-
-
Pascual, J.1
Falk, R.2
Docekal, R.3
-
22
-
-
0037159234
-
Eletriptan vs. sumatriptan A double-blind, placebo-controlled, multiple migraine attack study
-
Sandrini G, Farkkila M, Burgess G et al. (2002) Eletriptan vs. sumatriptan A double-blind, placebo-controlled, multiple migraine attack study. Neurology 59:1210-1217
-
(2002)
Neurology
, vol.59
, pp. 1210-1217
-
-
Sandrini, G.1
Farkkila, M.2
Burgess, G.3
-
23
-
-
0043029861
-
Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs
-
Schulman E, Dermott K (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43:729-733
-
(2003)
Headache
, vol.43
, pp. 729-733
-
-
Schulman, E.1
Dermott, K.2
-
24
-
-
0034050671
-
Low migraine headache recurrence with naratriptan: Clinical parameters related to recurrence
-
Sheftell F, O'Quinn S, Watson C et al. (2000) Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence. Headache 40:103-110
-
(2000)
Headache
, vol.40
, pp. 103-110
-
-
Sheftell, F.1
O'Quinn, S.2
Watson, C.3
-
25
-
-
0346958578
-
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine
-
Steiner T, Diener H, MacGregor E et al. (2003) Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia 23:942-952
-
(2003)
Cephalalgia
, vol.23
, pp. 942-952
-
-
Steiner, T.1
Diener, H.2
MacGregor, E.3
-
26
-
-
1642527471
-
Treatment of primary headache disorders with intravenous valproate: Initial outpatient experience
-
Stillman M, Zajac D, Rybicki L (2004) Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache 44:65-69
-
(2004)
Headache
, vol.44
, pp. 65-69
-
-
Stillman, M.1
Zajac, D.2
Rybicki, L.3
-
27
-
-
0032407703
-
Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
-
Tfelt-Hansen P, Teall J, Rodriguez F et al. (1998) Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 38:748-755
-
(1998)
Headache
, vol.38
, pp. 748-755
-
-
Tfelt-Hansen, P.1
Teall, J.2
Rodriguez, F.3
-
28
-
-
0033756633
-
Oral therapy for migraine: Comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials
-
Tfelt-Hansen P, Ryan RE (2000) Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials. Neurology 55 [suppl 2]:S19-S24
-
(2000)
Neurology
, vol.55
, Issue.SUPPL. 2
-
-
Tfelt-Hansen, P.1
Ryan, R.E.2
-
29
-
-
0033043501
-
Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal antiinflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
-
The Diclofenac-K/Sumatriptan Migraine Study Group (1999) Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal antiinflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia 19:232-240
-
(1999)
Cephalalgia
, vol.19
, pp. 232-240
-
-
-
30
-
-
0025772871
-
A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine
-
The Multinational Oral Sumatriptan Cafergot Comparative Study Group (1991) A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 31:314-322
-
(1991)
Eur Neurol
, vol.31
, pp. 314-322
-
-
-
31
-
-
3042830879
-
A phase III multicentre, randomized, double-blind, parallel-group study of valdecoxib 40 mg vs. placebo in patients with multiple moderate or severe acute migraine headaches with and without aura
-
abstr
-
Thomas HM, Kudrow DB, Ashford E et al. (2003) A phase III multicentre, randomized, double-blind, parallel-group study of valdecoxib 40 mg vs. placebo in patients with multiple moderate or severe acute migraine headaches with and without aura. Cephalalgia 23:697 (abstr)
-
(2003)
Cephalalgia
, vol.23
, pp. 697
-
-
Thomas, H.M.1
Kudrow, D.B.2
Ashford, E.3
-
32
-
-
0037218941
-
Prophylactic treatment of migraine with an angiotensin II receptor blocker, a randomized controlled trial
-
Tronvik E, Stovner L, Heide G et al. (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker, a randomized controlled trial. JAMA 289:65-69
-
(2003)
JAMA
, vol.289
, pp. 65-69
-
-
Tronvik, E.1
Stovner, L.2
Heide, G.3
|